Immunoregulation of hapten and drug induced immune reactions

Current Opinion in Allergy and Clinical Immunology

Volumn 3, Issue 4, 2003, Pages 243-247

  Cavani, Andrea ^a   Ottaviani, Chiara ^a   Nasorri, Francesca ^a   Sebastiani, Silvia ^a   Girolomoni, Giampiero ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Allergic contact dermatitis; CD4+CD25+ T cells; Haptens; Interleukin 10; Regulatory T cells

Indexed keywords

CD4 ANTIGEN; DRUG; HAPTEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; NICKEL;

DESENSITIZATION; DRUG HYPERSENSITIVITY; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOREGULATION; PRIORITY JOURNAL; REVIEW; SKIN; SKIN ALLERGY; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; T REGULATORY CELL 1 LIKE LYMPHOCYTE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DRUG HYPERSENSITIVITY; HAPTENS; HUMANS; RECEPTORS, INTERLEUKIN-2;

EID: 0042009746     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200308000-00002     Document Type: Review

References (41)

1. Pichler WJ, Yawalkar N, Britschgi M, et al. Cellular and molecular pathophisiology of cutaneous drug reactions. Am J Clin Dermatol 2002; 3:229-238.
2. Lu L, Vollmer J, Moulon C, Weltzien HU, et al. Components of the ligand for a Ni++ reactive human T cell clone. J Exp Med 2003; 197:567-574. These authors investigated the molecular mechanisms of nickel recognition by a T cell clone and established a general model for nickel interaction with MHC molecules and the TCR.
3. Wulferink M, Dierkes S, Gleichmann E. Cross-sensitization to haptens: formation of common haptenic metabolites, T cell recognition of cryptic peptides, and true T cell cross-reactivity. Eur J Immunol 2002; 32:1338-1348.
4. Nasorri F, Sebastiani S, Mariani V, et al. Activation of nickel-specific CD4+ T lymphocytes in the absence of professional antigen presenting cells. J invest Dermatol 2002; 118:172-179.
5. Sieben S, Kawakubo Y, Al Masaoudi T, Merk HF, et al. Delayed-type hypersensitivity reaction to paraphenylendiamine is mediated by 2 different pathways of antigen recognition by specific αβ+ human T-cell. J Allergy Clin Immunol 2002; 109:1005-1011.
6. Pichler WJ. Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol 2002; 2:301-305. This is a comprehensive review on the mechanisms of non-covalent T cell recognition of haptens.
7. Girolomoni G, Sebastiani S, Albanesi C, Cavani A. T cell subpopulations in the development of atopic and contact allergy. Curr Opin Immunol 2001; 13:733-737.
8. + T cell subsets against keratinocytes. J Immunol 2000; 165:3058-3064.
9. Trautmann A, Altznauer F, Akdis M, Simon HU, et al. The differential fate of cadherins during T-cell-induced keratinocyte apoptosis leads to spongiosis in eczematous dermatitis. J Invest Dermatol 2001; 117:927-934.
10. Albanesi C, Scarponi C, Sebastiani S, Cavani A, et al. A cytokine-to-chemokine axis between T lymphocytes and keratinocytes can favour Th1 cell accumulation in chronic inflammatory skin disease. J Leukoc Biol 2001; 70:617-623.
11. + dermal T cells from sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes. Br J Dermatol 1995; 132:215-220.
12. Mizukawa Y, Yamazaki Y, Teraki Y, et al. Direct evidence for interferon-γ production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption. Am J Pathol 2002; 161:1337-1347.
13. Hari Y, Frutig-Schnyder K, Hurni M, et al. T cell involvement in cutaneous drug eruption. Clin Exp Allergy 2001; 31:1398-1408.
14. Schmid S, Kuechler PC, Britschgi M, et al. Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation. Am J Pathol 2002; 161:2079-2086. This paper demonstrates the participation of cytotoxic events in the pathogenesis of generalized exanthematous pustolosis.
15. McHugh RS, Shevach EM. The role of suppressor T cells in the regulation of immune responses. J Allergy Clin Immunol 2002; 110:693-702.
16. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003; 3:253-257.
17. Roncarolo MG, Bacchetta R, Bordignon C, et al. Type 1 T regulatory cells. Immunol Rev 2001; 182:68-79.
18. Levings MK, Sangregorio R, Galbiati F, et al. IFN-alfa and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001; 166:5530-5539.
19. Jonuleit H, Schmitt E, Enk AH. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001; 22:394-400.
20. + T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J invest Dermatol 2000; 114:295-302.
21. + T cells act as suppressor cells by affecting autologous dendritic cells conditioning and survival. J Immunol 2002; 168:1060-1068. Anergic T cells affect antigen presentation and survival of dendritic cells.
22. Enk AH, Saloga J, Becker D, Madzedeh M, et al. Induction of hapten-specific tolerance by interleukin 10 in vivo. J Exp Med 1994; 179:1397-1402.
23. + T cells. J Immunol 2000; 164:2515-2522.
24. Artik S, Haarhuis K, Wu X, et al. Tolerance to nickel: oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity. J Immunol 2001; 167:6794-6803.
25. Schwarz A, Beissert S, Grosse-Heitmeyer K, et al. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance. J Immunol 2000; 165:1624-1831.
26. + T cells. J invest Dermatol 1998; 111:621-628.
27. + T lymphocytes with regulatory activity. J Immunol 2001; 166:996-1002.
28. + T regulatory cells.
29. + T cell differentiation, correlating Foxp3 expression with a T regulatory cell phenotype and function.
30. +CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigens. J Immunol 2001; 167:188-195.
31. + regulatory T cells by oral antigen administration. J Immunol 2001; 167:4245-4253.
32. + regulatory T cells are essential component of the memory-protective immunity to Candida albicans. J Immunol 2002; 169:6298-6308.
33. + T regulatory cells may have a critical role in the persistence of Leishmania major in the skin after healing, and in the resistance to reinfection.
34. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3:199-210.
35. + T cells to regulate in-vitro T cell responses to several exogenous antigens.
36. + T cells from synovial fluid of patients affected with rheumatoid arthritis.
37. + T regulatory cells, and characterizes their chemokine receptor asset, and migratory behaviour.
38. + T regulatory cells acquire a Tr1-like phenotype and suppress immune function through an interleukin-10 mediated mechanism.
39. + T cell expansion and function.
40. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, et al. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003; 197:403-411. This report shows that regulatory T cell function can be affected by bacterial products, underlying the critical link between innate and adaptive immunity in the control of immune responses.
41. + T regulatory cells through an interleukin-6 mediated mechanism.